LadRx starts hunt for new life; Statera lines up merger with diagnostics company

LadRx, formerly known as CytRx, will look for “strategic and financing alternatives,” the cancer biotech said Wednesday.

The Los Angeles biotech, listed on the over-the-counter market, said it initiated a process looking for a merger, strategic sale, up-listing to Nasdaq or other...

Click to view original post